Fresh Recalls

FDAClass I · Drug · Recall D-0692-2026 · Recalled July 8, 2026

Revitaderm Wound Care Gel recall — Blaine Labs Inc

Agency report date: July 8, 2026.

1. Compare your item

This notice names a product; your particular item is not yet verified. Compare every applicable model, serial, lot, production-date or model-year boundary below.

Product named
Revitaderm Wound Care Gel
Company / brand
Blaine Labs
Lot / serial / date codes
Lot#: BL3608, Exp. 07/01/28.
Distribution
Nationwide in the USA
Agency product description and boundaries

Revitaderm Wound Care Gel, Benzalkonium Chloride 0.1%, packaged in 1.0 FL OZ (37 mL) bottle, shorter twist cap, Manufactured By: Blaine Labs, Inc. 11037 Lockport Place Santa Fe Springs, CA 90670, NDC 63347-120-02.

Still to verify: match the label on your item with the full official notice, including any exclusions, tables and photos. Some identifiers appear only on the agency website and are absent from this data feed. A missing field does not mean all versions are affected.

If your lot or date falls outside a stated range, this notice has not established that your item is affected. This is not a finding about other recalls or product safety.

2. Agency hazard and consumer action

FDA reports: Microbial contamination of Non-Sterile Product: samples identified the presence of Lysinibacillus fusiformis and other Bacillus spp

No consumer remedy instructions are supplied in this record. Check the official notice and listed company contact for the agency’s current instructions.

Class I: most serious — reasonable probability of serious health consequences or death.

Affected product: Revitaderm Wound Care Gel

3. Open the official notice or contact

Official recall ID
D-0692-2026
Brand
Blaine Labs
Classification
Class I
Units affected
1,171 - 1 oz bottles
Recall status
Ongoing
Initiated
Voluntary: Firm initiated

Affected products

Companies & origin

Recalling firm location
Santa Fe Springs, CA, United States
Firm address
11037 Lockport Pl, N/A, 90670-4634

Identifying details (verbatim from the notice)

Product codes / lots
Lot#: BL3608, Exp. 07/01/28.
Distribution
Nationwide in the USA
Firm notified the public via
Press Release
FDA event ID
98731
Recall initiated
April 8, 2026
FDA classified
July 16, 2026
FDA report date
July 8, 2026
Verify with the official sources:

Found something wrong or missing? Report a data error.

Source: U.S. Food & Drug Administration. Agency excerpts come from the public data feed and may omit tables or later changes; the linked government source is authoritative. Source last checked September 7, 2026 at 6:00 AM UTC. Record retrieved September 7, 2026 at 6:00 AM UTC.

Report a data error on this page